LOGIN
Hyaluronic acid provides greater improvement than meloxicam for Kashin-Beck Disease
June 2013
Hyaluronic acid provides greater improvement than meloxicam for Kashin-Beck Disease
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin-Beck disease of the knee
Clin Rheumatol. 2012 Jul;31(7):1079-86. doi: 10.1007/s10067-012-1979-3. Epub 2012 Apr 3Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
162 patients with Kashin-Beck disease (KBD) were randomized to evaluate the efficacy and tolerability of hyaluronic acid (HA) and meloxicam for the treatment of KBD related knee pain. Patients were assigned to either a 3-week course of HA or a 12-week course of meloxicam. When assessed over a 12 week period, both treatments demonstrated significant improvements in pain. The onset of action of in t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.